Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

January 19, 2024

https://www.prnewswire.com/news-releases/oncolytics-biotech-recaps-2023-accomplishments-provides-outlook-for-2024-302025887.html

SAN DIEGO, CA and CALGARY, AB, Jan. 4, 2024 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX:ONC), a clinical-stage immunotherapeutics company focused on oncology, reported on significant 2023 accomplishments and announced corporate priorities and anticipated clinical development milestones for 2024.

Read more at prnewswire.com

Related news for (ONCY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.